Fiera Capital (Canada)’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.7M Buy
+255,104
New +$24.5M 0.09% 164

Other funds holding SYRE

Fiera Capital (Canada)'s SYRE Position: Q3 2026 in Review

Fiera Capital (Canada) opened a new position in Spyre Therapeutics (SYRE) in Q3 2026: 255,104 shares worth $22.7M. The stake represents 0.09% of the portfolio and ranks #164 among its holdings.

286 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.

  • Fiera Capital (Canada) held 255,104 shares of Spyre Therapeutics worth $22.7M as of Q3 2026.
  • Spyre Therapeutics was a new Fiera Capital (Canada) position in Q3 2026.
  • Spyre Therapeutics made up 0.09% of Fiera Capital (Canada)'s portfolio in Q3 2026, its #164 holding.
  • 286 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2026, filed 6 Nov 2026.